NURS 601 Assignment 3.1 Critique a Clinical Practice Guideline

Order ready-to-submit essays — 100% plagiarism-free guaranteed!

Note: Our papers are 100% human-written. 

Student Name

Maryville University

NURS 601 Evidence Based Practice in Nursing

Professor Name

Submission Date

AGREE II Score Sheet (Scope and Purpose of the Clinical Practice Guideline)

Dementia is a progressive neurological disorder caused by impaired cognitive functioning (memory, reasoning, and decision-making abilities). In the advanced stages of the condition, it poses a big burden on the physical ability and the independence of the person, and thus, people are unable to perform activities of daily living without support. Dementia can be presented in diverse ways, based on the type and the level of severity, and may include behavior and mood changes, and generally psychological well-being. These dynamic and complicated symptoms make healthcare providers adhere to well-structured and thoughtful care plans.

There are established clinical guidelines in the American Psychiatric Association with regard to the diagnosis, documentation, and management of dementia. These principles help healthcare workers to identify the symptoms early and undertake the necessary intervention. They also give comprehensive suggestions about pharmacological therapies, such as the correct use and dosage of the medication, and non-pharmacological therapies. These guidelines enhance the provision of continuous, evidence-based care that is responsive to patient needs by providing a structured framework.

According to the American Psychiatric Association, the main goal of these recommendations is to help formulate effective and holistic care approaches to people with dementia. As the condition has a complicated nature, the guidelines are developed with both medical and non-medical measures that will help in covering a broad spectrum of patient requirements. This is a holistic strategy that seeks to improve quality of life, diminish the burden of symptoms, slow down the disease progression, and ensure that the functional abilities are preserved as long as possible.

Moreover, the guidelines emphasize the significance of planning patient-centered care at the individual level. The individual symptoms, course of disease, and personal factors of individual patients are considered when choosing treatments and interventions. This is a customized care that makes care useful and up to date, where the variation among individuals is very high, like in dementia.

Stakeholder Involvement

This clinical practice guideline acknowledges the multidisciplinary team who were involved in its production, with experts like Aaron Gale, Kirsten Stoesser, Katherine Fortenberry, and Dominik Ose of the University of Utah Systematic Review Group. The guideline is directly aimed at helping healthcare providers in the proper use of antipsychotics in placing them in dementia patients who are agitated or psychotic. It highlights the importance of a thorough assessment of risks and benefits, focusing on enhancing patient outcomes and reducing the possibilities of adverse effects of these treatments (Gale et al., 2021).

Rigor of Development

 There are a few major features that were taken into account when developing this clinical practice guideline to make it rigorous, transparent, and clinically relevant. Prevention of bias based on a strong disclosure of conflict of interest was a high-ranking priority, and all the members of the review group had to disclose all possible conflicts at the onset, throughout, and after the guideline development process. The panel writing the guideline was specifically multidisciplinary, with clinicians, researchers, and stakeholders involved, providing a wide range of perspectives, including the opinions of patients and families. Also, the technique was enhanced by the efforts of professional review by the American Psychiatric Association Council and the workgroups, specifically, the data collection methods and systematic review procedures, as well as the diagnostic criteria of behavioral and psychological symptoms of dementia.

These standards were determined by the Institute of Medicine, the recommendations of the Council of Medical Specialty Societies, and the Agency for Healthcare Research and Quality, and were used in the development process. These frameworks guide the approach to methodological rigor, transparency, and involvement of stakeholders in the development of clinical guidelines. A snowball sampling strategy was adopted in order to attract highly experienced contributors to the study to ensure that the best individuals were included with great clinical experience on dealing with dementia, especially those who involve agitating or psychotic manifestations.

Additionally, the guideline employed the use of the GRADE (Grading of Recommendations Assessment, Development, and Evaluation) system to assess the quality of evidence and strength of recommendations. The internationally acclaimed framework assists in offering the advantages and risks of clinical interventions and facilitates evidence-based decision-making. All recommendations have well-defined levels of supporting recommendations, enabling the clinician to comprehend the basis of each guidance point.

In general, the systematic approach encompassing the choice of experts, the handling of conflicts of interest, the compliance with the international guidelines, and the grading of the evidence helps to make sure that the recommendations made in the final results can be regarded as credible, transparent, and applicable to clinical practice. Such an all-encompassing method renders the guideline more reliable, helps to provide better patient with dementia, especially the one having behavioral and psychological symptoms.

Applicability

In the section like Proper Use of Guidelines, APA emphasized that APA Practice Guidelines are reviews of current literature that ought to be utilized as educational aids and not as a standard (psychiatryonline, 2023). Some of the headings of the guideline include: Rating the Strength of Supporting Research Evidence, as appears on the page 29, Rating the Strength of Recommendations which is also on page 29, Practical Barriers to Measure Development, on page 25 and External Review, which is found on page 30 the paper by Silence and Wheatley demonstrates the effectiveness of organizational control in a persu The APA states that in assessing each of the recommendations, a level and strength of scientific evidence is attached to it.

Conclusion

Regarding the sub-sections in ‘Overview of studies’, each of them contains a section which states whether a particular organization or center has received funding or not; and an area in each of them that addresses publication bias Finally, I would give an overall quality of this guideline on the AGREE II Score Sheet a score of 6 out of 7 where 0 is the least quality and 7 is the highest quality. I discovered that the guideline has covered almost all the points of grading in the AGREE II Score Sheet, and conducted quality research on evidence-based research with qualified clinicians and evidence-based research data. As for me, I would like to apply this guideline with no changes. Data that was retrieved in this guideline will positively influence managing antipsychotics among patients with dementia.